PREDICTORS OF DISEASE COURSE AFTER THE DISCONTINUATION OF BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH LONG-TERM REMISSION

被引：1
|
作者：
Kadar, G. [1 ]
Czibula, A. [2 ]
Szalay, B. [3 ]
Nagy, K. [4 ]
Pusztai, A. [5 ]
Balog, A. [1 ]
Monostori, E. [2 ]
Vasarhelyi, B. [6 ]
Szekanecz, Z. [5 ]
Kovacs, L. [1 ]
机构：
[1] Univ Szeged, Dept Rheumatol, Szeged, Hungary
[2] Inst Genet, Biol Res Ctr, Szeged, Hungary
[3] Semmelweis Univ, Dept Lab Med, Budapest, Hungary
[4] Markhot Ferenc Hosp, Eger, Hungary
[5] Univ Debrecen, Dept Rheumatol, Fac Med, Debrecen, Hungary
[6] Semmelweis Univ, Dept Lab Med, Budapest, Hungary
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5753
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0312
引用
收藏
页码：1007 / 1007
页数：1
相关论文
共 50 条
  • [1] Predictors of Discontinuation of Biologic DMARD Therapy Due to Remission in Patients with Rheumatoid Arthritis in a National Registry
    Gomez-Puerta, Jose A.
    Victoria Hernandez, M.
    Sanchez-Alonso, Fernando
    Yoshida, Kazuki
    Sanmarti, Raimon
    Solomon, Daniel H.
    Gomez-Reino, Juan J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1097 - S1097
  • [2] BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON A SPANISH REGISTRY: PREDICTORS OF THERAPY DISCONTINUATION DUE TO REMISSION
    Hernandez, M. V.
    Gomez-Puerta, J. A.
    Canete, J. D.
    Gomez-Reino, J. J.
    Sanmarti, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 464 - 465
  • [3] PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE)
    Fornaro, Marco
    Cacciapaglia, Fabio
    Lopalco, Giuseppe
    Venerito, Vincenzo
    Schiraldi, Sante
    Renna, Daniela
    Laselva, Gaetana
    Scioscia, Crescenzio
    Lapadula, Giovanni
    Iannone, Florenzo
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1579 - 1579
  • [4] Predictors of long-term clinical remission in rheumatoid arthritis
    Fornaro, Marco
    Cacciapaglia, Fabio
    Lopalco, Giuseppe
    Venerito, Vincenzo
    Iannone, Florenzo
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (02)
  • [5] Long-term drug therapy of rheumatoid arthritis and remission
    Pyai, L
    Pyai, S
    [J]. TERAPEVTICHESKII ARKHIV, 2000, 72 (05): : 21 - 25
  • [6] LONG-TERM EFFECTIVENESS, DRUG SURVIVAL OF BIOLOGIC THERAPIES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS AND PREDICTIVE FACTORS OF DRUG DISCONTINUATION DUE TO DISEASE REMISSION
    Preedeekanit, K.
    Koolvisoot, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1139 - 1140
  • [7] REASONS AND RISK FACTOR FOR DISCONTINUATION OF BIOLOGIC AGENTS FOR RHEUMATOID ARTHRITIS PATIENTS IN LONG-TERM OBSERVATION
    Terabe, K.
    Takahashi, N.
    Asai, S.
    Hirano, Y.
    Kanayama, Y.
    Kojima, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1142 - 1143
  • [8] PREDICTIVE MARKER FOR THE LONG-TERM DISCONTINUATION OF INFLIXIMAB IN RHEUMATOID ARTHRITIS WITH CLINICAL REMISSION
    Yamasaki, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 245 - 245
  • [9] Long-term remission of psoriasis after discontinuation of efalizumab therapy
    Toth, DP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A44 - A44
  • [10] LONG-TERM FOLLOWUP OF BIOLOGIC AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Kaneko, Y.
    Kondo, H.
    Ohta, M.
    Takeuchi, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 465 - 466
12345